Authors:
SAKEMI T
YOSHIYUKI T
IKEDA Y
SUZUKI N
NAGASAWA K
Citation: T. Sakemi et al., END-STAGE RENAL-FAILURE DUE TO CRESCENTIC GLOMERULONEPHRITIS IN A PATIENT WITH BEHCETS-SYNDROME - REVIEW OF THE LITERATURE, American journal of nephrology, 18(4), 1998, pp. 321-324
Authors:
MATSUKURA N
ONDA M
KATO S
HASEGAWA H
YOSHIYUKI T
SHIRAKAWA T
TAKITA M
AKIYA Y
IKEDA K
OKAWA K
TOKUNAGA A
YAMAHATSU J
WEN M
YAMADA N
Citation: N. Matsukura et al., REVERSIBILITY OF INTESTINAL METAPLASIA IN THE STOMACH AFTER HELICOBACTER-PYLORI ERADICATION, Gastroenterology, 114(4), 1998, pp. 901-901
Authors:
MATSUKURA N
ONDA M
TOKUNAGA A
KATO S
YOSHIYUKI T
HASEGAWA H
YAMASHITA K
TOMTITCHONG P
HAYASHI A
Citation: N. Matsukura et al., ROLE OF HELICOBACTER-PYLORI INFECTION IN PERFORATION OF PEPTIC-ULCER - AN AGE-MATCHED AND GENDER-MATCHED CASE-CONTROL STUDY, Journal of clinical gastroenterology, 25, 1997, pp. 235-239
Authors:
ATSUNORI F
KAZUHIRO C
MIKI M
MASAYOSHI M
YOSHIYUKI T
Citation: F. Atsunori et al., EFFECTS OF SEVERAL HORMONES ON EXPRESSION OF VACUOLAR H-PYROPHOSPHATASE AND H+-ATPASE FROM BARLEY ROOTS(), Plant physiology, 114(3), 1997, pp. 978-978
Authors:
MATSUKURA N
ONDA M
OKAWA K
KATO S
HASEGAWA H
YOSHIYUKI T
TOKUNAGA A
YAMAHATSU J
YAMADA N
Citation: N. Matsukura et al., 2-STEP THERAPY FOR HELICOBACTER-PYLORI ERADICATION WITH LANSOPRAZOLE,AMOXICILLIN AND A MUCOSAL PROTECTIVE AGENT - ECABET SODIUM, Gastroenterology, 112(4), 1997, pp. 214-214
Authors:
MIYASHITA M
ONDA M
OKAWA K
MATSUTANI T
YOSHIYUKI T
SASAJIMA K
KYONO S
YAMASHITA K
Citation: M. Miyashita et al., ENDOSCOPIC DEXAMETHASONE INJECTION FOLLOWING BALLOON DILATATION OF ANASTOMOTIC STRICTURE AFTER ESOPHAGOGASTROSTOMY, The American journal of surgery, 174(4), 1997, pp. 442-444
Authors:
MATSUKURA N
ONDA M
SHIRAKAWA T
TAKITA M
AKIYA Y
OHKAWA K
YOSHIYUKI T
HASEGAWA H
KATO S
TOKUNAGA A
YAMAHATSU J
YAMASHITA K
Citation: N. Matsukura et al., HIGH ERADICATION RATE OF HELICOBACTER-PYLORI WITH LANSOPRAZOLE PLUS AMOXICILLIN PLUS ECABET SODIUM - NEW TRIPLE THERAPY WITH NOVEL MUCOSAL PROTECTIVE AGENT FOR THE TREATMENT OF PEPTIC-ULCER, Gastroenterology, 110(4), 1996, pp. 190-190
Authors:
TOKUNAGA A
ONDA M
OKUDA T
TERAMOTO T
FUJITA I
MIZUTANI T
KIYAMA T
YOSHIYUKI T
NISHI K
MATSUKURA N
Citation: A. Tokunaga et al., CLINICAL-SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR (EGF), EGF RECEPTOR,AND C-ERBB-2 IN HUMAN GASTRIC-CANCER, Cancer, 75(6), 1995, pp. 1418-1425